Komrokji RS - Search Results

1

Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.

Komrokji RS, Matacia-Murphy GM, Al Ali NH, Beg MS, Safa MM, Rollison DE, List AF. Komrokji RS, et al. Leuk Res. 2010 Jan;34(1):59-62. doi: 10.1016/j.leukres.2009.03.022. Epub 2009 Apr 14. Leuk Res. 2010. PMID: 19368972

2

Myelodysplastic syndromes: a view from where the sun rises and where the sun sets.

Komrokji R. Komrokji R. Leuk Res. 2006 Sep;30(9):1067-8. doi: 10.1016/j.leukres.2006.04.004. Epub 2006 May 24. Leuk Res. 2006. PMID: 16723153 No abstract available.

3

Male breast cancer in the veterans affairs population: a comparative analysis.

Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Nahleh ZA, et al. Cancer. 2007 Apr 15;109(8):1471-7. doi: 10.1002/cncr.22589. Cancer. 2007. PMID: 17342768 Free article.

4

Oxaliplatin-induced immune mediated thrombocytopenia.

Beg MS, Komrokji RS, Ahmed K, Safa MM. Beg MS, et al. Among authors: komrokji rs. Cancer Chemother Pharmacol. 2008 Oct;62(5):925-7. doi: 10.1007/s00280-007-0675-5. Epub 2008 Jan 19. Cancer Chemother Pharmacol. 2008. PMID: 18204841

5

Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry.

Beg MS, Navaneethan U, Atiq M, Komrokji R, Safa M. Beg MS, et al. Am J Clin Oncol. 2009 Jun;32(3):286-90. doi: 10.1097/COC.0b013e31818af0d8. Am J Clin Oncol. 2009. PMID: 19433959

6

Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis.

Kumar A, List AF, Hozo I, Komrokji R, Djulbegovic B. Kumar A, et al. Haematologica. 2010 Feb;95(2):340-2; author reply 343-4. doi: 10.3324/haematol.2009.017764. Epub 2009 Oct 22. Haematologica. 2010. PMID: 19850902 Free PMC article. No abstract available.

7

Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

Komrokji RS, List AF. Komrokji RS, et al. Hematol Oncol Clin North Am. 2010 Apr;24(2):377-88. doi: 10.1016/j.hoc.2010.02.013. Hematol Oncol Clin North Am. 2010. PMID: 20359632 Review.

8

Myelodysplastic syndromes classification and risk stratification.

Komrokji RS, Zhang L, Bennett JM. Komrokji RS, et al. Hematol Oncol Clin North Am. 2010 Apr;24(2):443-57. doi: 10.1016/j.hoc.2010.02.004. Hematol Oncol Clin North Am. 2010. PMID: 20359636 Review.

9

Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more?

Komrokji RS, Lancet JE, List AF. Komrokji RS, et al. Curr Hematol Malig Rep. 2010 Jan;5(1):9-14. doi: 10.1007/s11899-009-0036-z. Curr Hematol Malig Rep. 2010. PMID: 20425391 Review.

10

Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.

Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancet J, Brand L, Field T, Ayala E, Janssen W, List AF, Anasetti C. Kharfan-Dabaja MA, et al. Among authors: komrokji rs. Biol Blood Marrow Transplant. 2011 Mar;17(3):384-93. doi: 10.1016/j.bbmt.2010.07.011. Epub 2010 Jul 22. Biol Blood Marrow Transplant. 2011. PMID: 20655389 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters